- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about VRTX
Recent news which mentions VRTX
The 3 Best Biotech Stocks to Buy in August 2024
August 08, 2024
From InvestorPlace
Is It Too Late to Buy Vertex Pharmaceuticals Stock?
August 06, 2024
From Motley Fool
From Motley Fool
3 Biotech Stocks on Track for 50% Returns (or More) by 2028
August 04, 2024
From InvestorPlace
From Motley Fool
3 Unstoppable Stocks to Buy in August
August 03, 2024
From Motley Fool
Prediction: 2 Stocks That Will Be Worth More Than Johnson & Johnson 10 Years From Now
August 03, 2024
From Motley Fool
3 Biotech Stocks That Could Have Investors Grinning Soon
August 02, 2024
From InvestorPlace
Magnificent 7 Lose Over $300B As Volatility Index Surges, Traders Question Fed's Timing: What's Driving Markets Friday?
August 02, 2024
From Benzinga
Vertex Pharmaceuticals Lifts Annual Guidance, Positive Growth For Its Cystic Fibrosis Franchise And Pain Management Pipeline
August 02, 2024
From Benzinga
Should Investors Worry About Vertex Pharmaceuticals $3.6 Billion Q2 Loss? Not Even for a Second.
August 02, 2024
Tickers
VRTX
From Motley Fool
Vertex Pharmaceuticals (VRTX) Q2 2024 Earnings Call Transcript
August 01, 2024
Tickers
VRTX
From Motley Fool
US Stocks Tumble On Economic, Geopolitical Concerns; Small Caps, Chipmakers Sink; Meta Rallies: What's Driving Markets Thursday?
August 01, 2024
From Benzinga
Got $500? 2 Compelling Growth Stocks to Buy and Hold Forever
August 01, 2024
From Motley Fool
From Benzinga
The Top 3 Biotech Stocks to Buy Now Summer 2024
July 31, 2024
From InvestorPlace
DexCom Stock Plunged Over 40% Last Week. Are Eli Lilly's and Novo Nordisk's Drugs to Blame?
July 30, 2024
From Motley Fool
The Top 3 Cathie Wood Stocks to Buy Now: Summer 2024
July 29, 2024
From InvestorPlace
From Benzinga
2 No-Brainer Growth Stocks to Buy With $1,000 Right Now
July 28, 2024
From Motley Fool
Tickers
VRTX
From Motley Fool
7 Biotech Stocks to Keep on Your Clinical Radar
July 23, 2024
From InvestorPlace
Here's How Much $100 Invested In Vertex Pharmaceuticals 5 Years Ago Would Be Worth Today
July 23, 2024
From Benzinga
3 Gene Editing Stocks Shaping the Future of Medicine
July 22, 2024
From InvestorPlace
From Motley Fool
3 Monster Stocks in the Making to Buy Right Now
July 20, 2024
From Motley Fool
The 3 Best Neuroscience Biotech Stocks to Buy Now
July 19, 2024
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.